Global Innovative Platforms Inc. (GIPL) develops non-invasive breath analysis technologies for disease detection and air quality monitoring, primarily targeting animal health applications. The company offers proprietary VOCAM Plus and FROG platforms utilizing gas chromatography for breathomics diagnostics; Heartworm breath test kits including breath samplers and collection tools; and artificial intelligence software for breath and air analysis to assess treatment effectiveness and environmental toxins. Incorporated in 2020 and headquartered in Sanford, Florida, Global Innovative Platforms Inc. operates in the healthcare equipment sector with a focus on veterinary diagnostics. In November 2025, the company entered an agreement with a global animal health firm to supply VOCAM Plus units and support services for evaluating heartworm detection in dogs; completed the first phase of a breath-based study analyzing over 100 canine samples for early heartworm markers; posted an updated investor presentation with preliminary AI breath data; transitioned auditors by dismissing M. S. Madhava Rao and appointing CNGSN & Associates LLP; and in October 2024 secured $311,000 in funding from seven investors.